GILEAD SCIENCES, INC. Long-Term Debt
GILEAD SCIENCES, INC. (GILD) had Long-Term Debt of $23.83 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $23.83B.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $20.86B.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $22.13B.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $22.14B.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $23.83B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $20.86B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $22.13B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $22.14B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $22.14B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $22.15B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $24.90B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $21.44B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $21.54B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $21.53B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $23.19B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $23.19B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $21.21B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $22.96B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $22.96B 10-K · filed 2024-02-23 | |
| 2022-09-30 | $22.95B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $25.20B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $25.18B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $25.18B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $25.18B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $27.91B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $27.91B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $28.64B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $27.79B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $21.10B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $22.10B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $22.09B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $22.09B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $24.08B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $24.08B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $24.57B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $24.57B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $26.06B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $26.56B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $30.80B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $27.52B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $26.30B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $26.32B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $26.35B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $26.37B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $21.43B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $21.08B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $21.07B 10-K · filed 2017-02-27 | $21.20B 10-K · filed 2016-02-24 |
| 2015-09-30 | $21.89B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $11.92B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $11.92B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $11.92B 10-K · filed 2016-02-24 | |
| 2014-09-30 | $7.93B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $7.93B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $7.93B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $3.94B 10-K · filed 2015-02-25 | $3.94B 10-K · filed 2014-02-25 |
| 2013-09-30 | $5.86B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $5.85B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $7.05B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $7.05B 10-K · filed 2014-02-25 | |
| 2012-09-30 | $7.04B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $7.13B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $8.08B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $7.61B 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |